(Q49796350)

27 February 2018

title

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients. (English)

1 reference

27 February 2018

0 references

1 reference

Christopher Seungkyu Lee

object named as

Christopher Seungkyu Lee

series ordinal

2

0 references

author name string

Ji Hwan Lee

series ordinal

1

1 reference

27 February 2018

Sung Chul Lee

series ordinal

3

1 reference

27 February 2018

publication date

20 February 2018

1 reference

27 February 2018

published in

BMC Ophthalmology

1 reference

27 February 2018

volume

18

1 reference

27 February 2018

issue

1

1 reference

27 February 2018

page(s)

52

1 reference

27 February 2018

https://scigraph.springernature.com/pub.10.1186/s12886-018-0719-0

exact match

0 references

cites work

Long-term Efficacy of Interferon in Severe Uveitis Associated with Behçet Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Tocilizumab in severe and refractory non-infectious uveitis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Uveitis in Behçet's disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

A controlled trial of azathioprine in Behçet's syndrome

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819294

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

30 November 2018

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease

1 reference

12 December 2020

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

12 December 2020

Results of interferon alpha-2a therapy in patients with Behcet's disease

1 reference

12 December 2020

Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis

1 reference

12 December 2020

10.1186/S12886-018-0719-0

Identifiers

DOI

1 reference

27 February 2018

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s12886-018-0719-0

PMCID

5819294

1 reference

27 February 2018

PubMed ID

29463220

1 reference

27 February 2018